Issue No 09+10/2008


Serum Zinc and Copper Status in Dyslipidaemic Patients with and without Established Coronary Artery Disease

by Majid Ghayour-Mobarhan, Andrew Taylor, Seyyed Mohammad Reza Kazemi-Bajestani, Susan Lanham-New, David J Lamb, Nandita Vaidya, Callum Livingstone, Tim Wang, Gordon AA Ferns

Advanced Glycated Human Serum Albumin as AGE-Carrier Protein in Enzyme-Linked Immunosorbent Assay

by Bojan Benko, Zdenka Turk

Comparison of High-Sensitivity C-reactive Protein Serum Assay Results Obtained Using Dade-Behring BNII Nephelometer and Ortho Vitros FS 5.1 Clinical Analyzer in Respect of CRP-Related Risk Assessment of Chronic Metabolic Diseases

by Beata Kusnierz-Cabala, Wojciech Gernand, Anna Zabek-Adamska, Aleksandra Tokarz, Jerzy W. Naskalski

Clinical Performance of Six Different Serum Tartrate-resistant Acid Phosphatase Assays for Monitoring Alendronate Treatment

by Katja M. Fagerlund, Anthony J. Janckila, Hannele Ylipahkala, Sari L. Tiitinen, Arja Nenonen, Sulin Cheng, Kirsti Uusi-Rasi, Lung T. Yam, H. Kalervo Väänänen, Jussi M. Halleen

Eliminating Heterophilic Antibody Interference for Ferritin Detection Using Olympus F(ab’)2 Based Reagent

by Eric Grouzmann, Nicole Dayer, Catherine Bain, Claire M. Neville, Matthew D. McCusker, Robert Y. Wang

Comparison of Performance of Classical Clinical Chemistry Analysers with Test-Strip Devices (Reflotron) and those based on Film Technology (Vitros) in External Quality Assessment (EQA) Surveys

by William Graham Wood

Likelihood Ratios Reporting in a Tertiary Hospital Emergency Department; a Pilot Study

by Mariacaterina Maconi, Romolo M. Dorizzi, Roberto Baricchi, Maria Piera Ferrini, Debora Formisano, Maria Ferrari, Maria Brini

Prospective Comparative Evaluation of an Office-based Rapid Immunological Test with a Guaiac-based Fecal Occult Blood Test for Colorectal Cancer Screening in General Population with Average-Risk

by Yogesh M. Shastri, Stefan Marcel Loitsch, Roland Nowak, Nada Povse, Jürgen Stein

Comparison of a Novel Fecal Marker- Fecal Tumor Pyruvate Kinase Type M2 (M2-PK) with Fecal Calprotectin in Patients with Inflammatory Bowel Disease: a Prospective Study

by Yogesh M. Shastri, Nada Povse, Oliver Schröder, Jürgen Stein